Skip to content
2000
Volume 17, Issue 8
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Objective/Method: A series of 4H-chromen-4-one derivatives (A1-A16) have been designed and synthesized, and they were screened for BRAF kinase inhibitory activity. Furthermore, their biological activities were evaluated in vitro. Result: Compounds A03 and A10 displayed the most potent antiproliferative activity against human osteosarcoma cell line (U2OS) and A16 displayed the most potent antiproliferative activity against human melanoma cancer cell line (A375) in vitro, which was valuable to study further.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520615666160504094945
2017-07-01
2025-06-23
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520615666160504094945
Loading

  • Article Type:
    Research Article
Keyword(s): 4H-Chromen-4-one; anticancer activity; BRAF (V600E) kinase; design; in vitro; synthesis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test